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Helicobacter pylori is a pathogenic bacterium that has the remarkable ability to withstand the harsh
conditions of the stomach for decades. This is achieved through unique evolutionary adaptations, which
include binding Lewisb antigens found on the gastric epithelium using the outer membrane protein BabA.
We show here the yield of a recombinant form of BabA, comprising its putative extracellular binding
domain, can be signiﬁcantly increased through the addition of a hexa-lysine tag to the C-terminus of
the protein. BabA was expressed in the periplasmic space of Escherichia coli and puriﬁed using
immobilised metal ion afﬁnity and size exclusion chromatography – yielding approximately 1.8 mg of
protein per litre of culture. The hexa-lysine tag does not inhibit the binding activity of BabA as the recom-
binant protein was found to possess afﬁnity towards HSA–Lewisb glycoconjugates.
 2014 The Authors. Published by Elsevier Inc. This is an open access article under theCCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Helicobacter pylori is a microaerophilic gram-negative bacte-
rium that is estimated to infect over half of the world’s population
[1]. This bacterium, which displays a very strict tissue tropism in
humans for gastric mucosa, is an established cause of chronic gas-
tritis and a major risk factor for the development of peptic ulcers
and gastric cancer [2,3]. Using adhesion proteins to attach directly
to the gastric epithelium, H. pylori is able to evade gastric mucus
turnover and colonise the human stomach for several years [4].
One of the best characterised adhesins is the blood group
antigen-binding adhesin (BabA)1 [5]. The native 80 kDa protein
is predicted to have similar domain structures to other outer
membrane proteins from the Hop (Helicobacter outer membrane
porins) superfamily [6]. This consists of an extracellular N-terminal
domain, involved in binding to host receptors, and a transmembrane
C-terminal domain, predicted to form a b-barrel structure similar tocrystallised porins [7]. It is well established that the bacteria use the
BabA protein to bind to the Lewisb (Leb) antigen, which is an
oligosaccharide abundantly present in the gastric mucosa of the
majority of the Western population [8–10]. As a result of its impor-
tant role in gastric adherence, BabA plays a signiﬁcant role in
enhancing H. pylori virulence [11], and may represent a potential tar-
get for eradication therapy.
Given its clinical relevance, techniques to express recombinant
BabA are of high importance to support biophysical and structural
studies. Recently, there have been a number of reports describing
successful expression strategies, all of which have used Escherichia
coli as a host. These have included refolding from inclusion bodies
[12], expression as a fusion protein using glutathione S-transferase
(GST) as a solubility enhancing partner [13], and secretion to the
periplasmic space [14]. However, each of these approaches has
drawbacks. Refolding from inclusion bodies is time-consuming
and proteins may not regain full function [15,16], GST-fusion
proteins often require partner cleavage before NMR and crystallo-
graphic structure determination [17], and periplasmic expression
is associated with low yield [18].
Indeed, our initial attempts to recombinantly express the
N-terminal extracellular domain of BabA were challenging.
Over-expression in the cytoplasm of E. coli led to the formation
of insoluble aggregates and secretory expression in eukaryotic
hosts was unsuccessful. Although fusion with a pelB leader
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space, the BabA fragment lacked solubility and we failed to obtain
high yields of puriﬁed protein using this strategy.
We therefore investigated the use of a polycationic amino acid
tag to increase protein solubility. Recent studies have shown that
incorporating up to ten residues of arginine or lysine, at one
terminus of a recombinant protein, can greatly improve solubility
[19–22]. We show here that the addition of a hexa-lysine tag at
the C-terminus signiﬁcantly enhances the expression and puriﬁca-
tion of BabA and does not interfere with Lewisb binding. This strat-
egy will facilitate structural and biophysical characterisation of the
H. pylori outer membrane protein BabA, and thus, provide insight
into H. pylori adherence mechanisms.
Experimental procedures
Bacterial strains and plasmids
E. coli XL10 Gold cells (Agilent Technologies, USA) were
employed both for vector construction and protein expression
using a modiﬁed pOPE101 expression vector (Progen Biotechnik,
Germany).
Expression vector construction
Genomic DNA isolated from H. pylori J99 was used in a polymer-
ase chain reaction to amplify a 1581 bp BabA gene fragment
encoding its extracellular/putative binding domain (amino acids
21–547; GenBank accession no. AAD06409.1). The ﬁrst 20 amino
acids were excluded as they encode a cleavable signal sequence
for translocation to the H. pylori outer membrane through the
Sec pathway, while amino acids 548–744 are predicted to be
involved in the formation of the transmembrane b-barrel domain
[7,14]. Gene ampliﬁcation was achieved using KOD DNA polymer-
ase (Novagen, Germany) and primers were designed to introduce
the necessary restriction sites (Table 1) for incorporation into the
pOPE101 expression vector (Progen Biotechnik, Germany).
Following ampliﬁcation, PCR products were gel-puriﬁed using a
QIAquick Gel Extraction Kit (Qiagen, USA) then double-digested
alongside the pOPE101 expression vector using NcoI and BamHI
restriction enzymes (New England Biolabs, USA). The BabA gene
fragments were ligated into the expression vectors using T4 DNA
ligase (New England Biolabs, USA) and transformed into chemically
competent E. coli XL10 Gold cells for plasmid propagation. After
veriﬁcation of successful transformation using colony PCR, plasmid
constructs were puriﬁed using a QIAprep miniprep kit (Qiagen,
USA) and sequenced by Source BioScience (Nottingham, UK), to
verify homology to the BabA J99 gene.
Protein expression
E. coli XL10 Gold cells containing BabA547 or BabA547-6K
expression constructs were grown in lysogeny broth (supple-
mented with 100 lg/mL ampicillin, 12.5 lg/mL tetracycline and
0.1 M glucose) at 37 C until the OD600 reached 0.6. At this point,Table 1
Primers used for gene ampliﬁcation. The recognition sites for the stated restriction
enzymes are underlined. [FOR] and [REV] denote forward and reverse primers,
respectively.
Name Sequence (50–30)
BabA [FOR] 21- NcoI TCGGATCCATGGAAGACGACGGCTTTTAC
BabA [REV] -547 BamHI CGAGTTGGATCCGAGTTCTTGGTTGATGG
BabA [REV] -547(6K) BamHI TCTGCTGGATCCCTTCTTCTTCTTCTTCTTGAG
TTCTTGGTTGATGGthe temperature was reduced to 24 C and expression was induced
with isopropyl b-D-1-thiogalactopyranoside (IPTG) to a ﬁnal
concentration of 0.1 mM. After 16 h, cells were harvested through
centrifugation and an osmotic shock procedure was used to extract
proteins from the periplasmic space [23].
Periplasmic extracts were boiled in a non-reducing SDS sample
buffer and separated by SDS–PAGE on a 4–20% Mini-PROTEAN TGX
gel (Bio-Rad, USA) and either visualised with Coomassie blue stain-
ing or transferred onto a nitrocellulose membrane for immunode-
tection using the c-Myc epitope tag. Western blotting, using a
chemiluminescence detection method, was performed with a bio-
tinylated mouse anti c-Myc [clone 9E10] antibody and Streptavi-
din:HRP (AbD Serotec, USA), both at a 1:5000 dilution. Total cell,
culture medium and cytoplasmic fractions were similarly analysed
under non-reducing conditions with Coomassie staining or c-Myc
immunodetection. Total cell fractions were prepared by resus-
pending and boiling harvested cells in non-reducing SDS sample
buffer. Culture medium fractions were prepared by concentrating
proteins from the culture supernatant after cell harvesting with tri-
chloroacetic acid followed by boiling in non-reducing SDS sample
buffer. Cytoplasmic fractions were prepared by boiling sphero-
blasts (cells after periplasmic extraction) in non-reducing SDS sam-
ple buffer. Non-reducing conditions were used as the recombinant
BabA proteins do not form intermolecular disulphide bonds,
although they contain eight cysteine residues.
Protein puriﬁcation
An osmotic shock method was used to obtain periplasmic
extracts. Brieﬂy, harvested cells were resuspended and gently sha-
ken in a tenth their culture volume of spheroblast solution (20%
sucrose, 1 mM EDTA, 50 mM Tris–HCl, pH = 8.0) on ice for one
hour. Cells were then pelleted, resuspended and gently shaken
again in a tenth of their culture volume of 5 mM MgSO4 on ice
for one hour and pelleted once more. Solutions used for cell resus-
pension contained complete EDTA-free protease inhibitor cocktail
tablets (Roche, USA), according to the manufacturer’s instructions.
The supernatant fractions obtained at both steps represent the
periplasmic extract and were subsequently used for recombinant
protein puriﬁcation.
The recombinant BabA proteins were puriﬁed from the peri-
plasmic extracts using their 6His tags through immobilised metal
ion afﬁnity chromatography with EDTA-resistant Ni Sepharose
excel resin (GE Healthcare, USA). Using an ÄKTApuriﬁer system
(GE Healthcare, USA), BabA547 and BabA547-6K proteins were
eluted with a step gradient of imidazole (up to 500 mM) in buffer
containing 20 mM Tris–HCl (pH = 7.4), 300 mM NaCl. As a ﬁnal
puriﬁcation step, size exclusion chromatography using a HiLoad
16/60 Superdex 75 gel ﬁltration column (GE Healthcare, USA)
was performed. The ﬁnal storage buffer was 20 mM Tris–HCl
(pH = 7.4), 300 mM NaCl. Protein concentration for periplasmic
extracts and immobilised metal ion afﬁnity chromatography elu-
tions was determined with a Bradford assay reagent (Bio-rad,
USA), using BSA as a standard [24]. Image analysis using ImageJ
(http://imagej.nih.gov/ij/) was used to verify the purity of proteins
on Coomassie stained SDS–PAGE gels. Western blotting, as
described above, to detect the c-Myc epitope tag was also
employed. The concentration of puriﬁed BabA was determined by
measuring absorbance at 280 nm using an extinction coefﬁcient
of 37290 M1 cm1 (calculated from the amino acid sequences of
BabA547-6K) on a Nanodrop 2000 (Thermo Scientiﬁc, USA).
Mass spectrometry analysis
Liquid chromatography–time-of-ﬂight mass spectrometry was
used to determine the molecular weights of proteins in puriﬁed
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tein samples were loaded onto an Agilent 1100 Series LC (Agilent
Technologies, USA) coupled to a time-of-ﬂight Q-Tof Premier mass
spectrometer (Waters, USA), which was equipped with an electron
spray ioniser for acquisition in a positive ionisation mode. The
mass scan range was set to 500–2000m/z and MassLynx (Waters,
USA) was used to analyse the mass data.
N-terminal sequencing was used for determination of the ﬁrst
ﬁve amino acids of the pure BabA547-6K protein through Edman
degradation (AltaBiosciences, Birmingham).
Tryptic peptide mapping was performed on gel slices of puriﬁed
BabA protein bands after size exclusion chromatography. Brieﬂy,
bands were reduced with 10 mM DTT for 45 min at 65 C, followed
by alkylation of protein thiols by incubation with 50 mM iodoacet-
amide in the dark at room temperature for 20 min. Digestion of the
proteins was performed using 250 ng of trypsin for 16 h at 37 C.
Resulting fragments were analysed by liquid chromatography–
quadrupole time-of-ﬂight mass spectrometry. An UltiMate 3000
Nano LC system (Dionex, USA) coupled to a QSTAR Elite System
(AB Sciex, USA) – a hybrid quadrupole time-of-ﬂight mass spec-
trometer ﬁtted with electrospray ionisation for acquisition in a
positive ionisation mode – was used. Mascot (Matrix Science,
USA) was used to analyse data.Binding activity of recombinant BabA
HSA (Sigma Aldrich), HSA–Ley and HSA–Leb glycoconjugates
(Isosep AB, Sweden) were immobilised at a concentration of
5.0 lg/mL on Maxisorp plates (Thermo Scientiﬁc, USA) and incu-
bated with BabA547-6K in concentrations ranging from 1.0 to
20 lg/mL. A mouse anti-c-Myc biotinylated antibody (AbD Serotec,
USA) and streptavidin-HRP (AbD Serotec, USA), both at a 1:2000
dilution, were added sequentially to complex with bound recombi-
nant BabA to enable tetramethylbenzidine chromogenic detection.
Absorbance was measured at 450 nm on a microplate reader
(Dynex Technologies, USA).Results
Protein expression
To improve the expression and puriﬁcation of the H. pylori outer
membrane protein BabA, we introduced a C-terminal hexa-lysine
tag to a modiﬁed pOPE101 expression vector designed to secrete
BabA proteins into the E. coli periplasmic space. Expression condi-
tions of our BabA constructs, shown in Fig. 1, were kept identical in
order to observe any effects of the hexa-lysine tag. SimilarA
B
Fig. 1. Schematic diagram of (A) pOPE101-BabA547 and (B) pOPE101-BabA547-6K expres
restriction enzyme sites. The abbreviations and symbols represent the following: Pro –
transcriptional start; pelB – cleavable pelB leader sequence; BabA547 – BabA gene fragme
histidine peptide tag; X/STOP – UAA stop codon/transcriptional termination.polycationic amino acid tags have been reported to improve the
expression and solubility of other proteins [19–22].
Following induction with IPTG and overnight incubation,
periplasmic proteins were extracted from the E. coli cells based
on a well-established osmotic shock procedure in the presence of
protease inhibitors [23]. Periplasmic proteins were separated via
SDS–PAGE and visualised with both Coomassie staining and
c-Myc immunodetection (Fig. 2).
As shown in Fig. 2, it is clear that there are higher levels of
c-Myc tagged recombinant protein in the periplasmic extracts,
upon the addition of the hexa-lysine tag to the C-terminus of
BabA547. We further investigated whether the hexa-lysine tag
increased the total amount of protein expressed or just the amount
of protein secreted to the periplasmic space. Total cell, culture
medium and spheroblast (E. coli cells with an extracted periplasmic
space) fractions were similarly analysed via Coomassie staining
and Western blotting. We found the presence of both BabA547
and BabA547-6K proteins is completely limited to the periplasmic
space (Supporting Information, Figs. A.1 and A.2). The difference
in expression levels can also be seen in total cell fractions, suggest-
ing the hexa-lysine tag has an inﬂuence on total expressed protein
levels.
Protein puriﬁcation
Recombinant BabA proteins were ﬁrst puriﬁed from E. coli
periplasmic extracts by immobilised metal ion afﬁnity chromatog-
raphy (IMAC); the purity of both recombinant proteins was rela-
tively low after this procedure, as ascertained by Coomassie
staining (Supporting Information, Fig. A.3). A major contaminant
with a molecular weight between 37 and 50 kDa was also consis-
tently observed in BabA547 IMAC-puriﬁed fractions, but not in
BabA547-6K IMAC-puriﬁed fractions. Furthermore, as shown in
Table 2, the yield of BabA547 was signiﬁcantly lower after IMAC
puriﬁcation, compared to BabA547-6K. This poor recovery following
IMAC puriﬁcation is attributed to aggregate formation observed
after protein elution with imidazole. These aggregates were sepa-
rated via centrifugation and excluded from protein quantiﬁcation
and further puriﬁcation steps.
In both cases, size exclusion chromatography (SEC) was used as
a ﬁnal puriﬁcation step. As shown in Fig. 3, BabA547-6K IMAC-
puriﬁed proteins eluted predominantly as a monomer off the gel
ﬁltration column at elution volume (Ve) 60–70 mL. On the other
hand, BabA547 IMAC-puriﬁed proteins were found to have different
characteristics in that elution began in the void volume (Ve 6
46.5 mL), suggesting the presence of aggregates. Peak fractions
(Ve = 60–70 mL) were collected for both proteins for further
characterisation.sion cassettes. Inserts were cloned into the pOPE101 vector using NcoI and BamHI
synthetic lac promoter (P/A1/04/03); lacO – lac operator; arrow – AUG start codon/
nt; 6x Lys – hexa-lysine peptide tag; c-Myc – Myc 9E10 epitope tag; 6x His – hexa-
Fig. 2. Secretion of recombinant BabA547 and BabA547-6K into the periplasmic space. Coomassie staining (left) and c-Myc immunodetection (right) of periplasmic extracts
from E. coli XL10 Gold cells containing pOPE101-BabA547 and pOPE101-BabA547-6K expression constructs. The () symbol represents uninduced cell samples while (+)
represents cell samples induced with 0.1 mM IPTG at 24 C for 16 h. Equal amounts of sample were loaded. The BabA proteins are indicated by black arrows.
Table 2
Summary of BabA547 and BabA547-6K puriﬁcation.
Step BabA547 BabA547-6K
Total proteinb
(mg)
Target proteinb
(mg)
Yield
(%)
Purityc
(%)
Total proteinb
(mg)
Target proteinb
(mg)
Yield
(%)
Purityc
(%)
Periplasmic extracta 276 18 100 6.4 284 26 100 9.3
Immobilised metal ion afﬁnity
chromatography
22 3.3 19 15 31 20 76 65
Size exclusion chromatography 2.4 0.8 4.4 33 18 18 67 99
a From 10 l of E. coli culture induced with 0.1 mM IPTG for 16 h at 24 C.
b Total protein determined by Bradford assay (BSA as standard protein).
c Purity estimated from ImageJ analysis of a scanned Coomassie stained SDS–PAGE gel by measuring target band as a fraction of all bands.
Fig. 3. Size exclusion chromatography traces of BabA547 and BabA547-6K proteins
puriﬁed through immobilised metal ion afﬁnity chromatography. Recombinant
proteins were loaded onto a HiLoad 16/60 Superdex 75 column after immobilised
metal ion afﬁnity chromatography.
Fig. 4. (A) Coomassie stained SDS–PAGE gel and (B) Molecular mass proﬁle of
puriﬁed BabA547-6K. IMAC and SEC puriﬁed BabA547-6K was used for both SDS–
PAGE and liquid chromatography–time-of-ﬂight mass spectrometry. The observed
molecular weight of BabA547-6K is 1014 Da smaller than its expected molecular
weight – 59,213 Da. This corresponds to a loss of its ﬁrst nine amino acids (Amino
acid sequence: EDDGFYTSV).
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Mass spectrometry was used to verify the molecular weight of
the puriﬁed recombinant BabA proteins. Surprisingly, the observed
molecular weights of both BabA547 and BabA547-6K were 1014 Da
smaller than their expected molecular weight (Figs. 4B and 5B).
This was a repeated ﬁnding after puriﬁcation and corresponds to
a loss of the ﬁrst nine amino acids of the expected BabA proteins
– Edman degradation was used to conﬁrm this (data not shown).
We speculate that this N-terminal truncation occurs during pelB
leader cleavage, upon periplasmic secretion, but further experi-
mentation is needed to conﬁrm this.Mass spectrometry was also used, alongside Coomassie staining
of SDS–PAGE gels containing puriﬁed recombinant BabA proteins,
to assess ﬁnal purity. For BabA547-6K, a single protein of high pur-
ity was found (Fig. 4). On the other hand, the Coomassie stained gel
of puriﬁed BabA547 contained two protein bands (Fig. 5A), which
match the two prevalent proteins found after IMAC puriﬁcation
(Supporting Information, Fig. A.3). The larger protein band could
be detected using monoclonal antibodies directed to C-terminal
c-Myc epitope tag, but this was not the case with the lower protein
Fig. 5. (A) Coomassie stained SDS–PAGE gel and (B) Molecular mass proﬁle of
puriﬁed BabA547. IMAC and SEC puriﬁed BabA547 was used for both SDS–PAGE and
liquid chromatography–time-of-ﬂight mass spectrometry. The observed molecular
weight of BabA547 is 1014 Da smaller than its expected molecular weight –
58,444 Da. This corresponds to a loss of its ﬁrst nine amino acids (Amino acid
sequence: EDDGFYTSV).
Fig. 7. Binding speciﬁcity of recombinant BabA547-6K. Binding of Recombinant
BabA to immobilised HSA, Lewisy–HSA and Lewisb–HSA glycoconjugates was
determined using a sandwich ELISA (n = 3, error bars represent the standard error of
the mean). ns = not signiﬁcant (P > 0.05), paired two-tailed t-test.
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band actually consisted of four lower molecular weight proteins,
differing only in size by a few amino acids (Fig. 5B).
As this is a characteristic of protein degradation, the additional
lower band was excised and subjected to tryptic digestion for
peptide mapping. This analysis conﬁrmed that the lower band
consisted of peptide fragments of BabA547 (45% sequence coverage;
Fig. 6). Moreover, this truncation appears to occur at the
C-terminus of the BabA547 protein as no peptide masses after
K383 were matched and, as previously mentioned, the C-terminal
c-Myc epitope tag could not be detected. As these degradative frag-
ments would consequently lack their C-terminal 6xHis tag, their
appearance in IMAC puriﬁcation fractions are probably the result
of non-speciﬁc binding to the Ni sepharose excel resin, particularly
given no imidazole is used in equilibration and sample buffers [25].
Because no degradative fragments were found with the BabA547-6K
protein following puriﬁcation, we suggest the hexa-lysine tag may
also prevent proteolytic degradation in addition to enhancing
solubility.
Binding activity of recombinant BabA
Finally, we assayed the interaction between recombinant BabA
and the Lewisb oligosaccharide. The binding activity of the BabA547
protein could not be appropriately characterised due to poor
protein yield and purity. However, BabA547-6K was studied in a
sandwich ELISA format where Lewisb–HSA glycoconjugates were
immobilised on Maxisorp plates and bound protein detectedFig. 6. BabA547 amino acid sequence showing matched peptides identiﬁed after
tryptic digest of contaminant protein. The peptides underlined were identiﬁed
through peptide mass matching only, after liquid chromatography–quadrupole
time-of-ﬂight mass spectrometry. Trypsin cleavage sites (C-term side of lysine [K]
or arginine [R] unless next residue is proline [P]) are highlighted in bold.through antibodies directed against the C-terminal c-Myc tag.
Unconjugated HSA and Lewisy–HSA glycoconjugates were also
included to assess BabA547-6K binding speciﬁcity.
As shown in Fig. 7, the BabA547-6K protein retained its binding
afﬁnity towards Lewisb–HSA glycoconjugates in a concentration
dependent manner. Additionally, this recombinant BabA pro-
tein does not display non-speciﬁc binding towards HSA or
Lewisy–HSA glycoconjugates.Discussion
A method to efﬁciently produce a recombinant form of BabA is
desirable to support biophysical and structural studies. However,
expression and puriﬁcation of soluble BabA in our lab proved to
be very challenging. A recent report described successful expres-
sion of an active protein in the periplasmic space of E. coli XL10
Gold cells using a pOPE101 vector [14]. Based on this expression
strategy, we show here that a C-terminal hexa-lysine tag enhances
the expression and puriﬁcation of a recombinant BabA protein that
contains amino acids 10–547 of the mature, native protein from
strain J99.
We initially hypothesised that a hexa-lysine tag would improve
the solubility of BabA547 and, as such, reduce the amount of
aggregates observed after IMAC puriﬁcation. Although this effect
was noticed, we also found a signiﬁcant increase in expressed
BabA547-6K levels in the periplasmic space. The improved expres-
sion was due to an increase in the total amount of recombinant
BabA rather than an increase in the ratio of protein found in the
periplasmic space to other cellular compartments or secreted
fractions.
The hexa-lysine tag appears to protect against proteolytic deg-
radation resulting in an increased yield of BabA as a considerable
amount of degradative fragments are found in BabA547, but not
BabA547-6K, puriﬁed fractions. The mechanism or location of pro-
tein degradation is uncertain, but BabA547 digestion may very well
occur during expression. Indeed, the periplasmic space of E. coli is
known to host at least 20 proteases with various functionalities
[26]. The protease DegP is known to degrade recombinant proteins
that are misfolded upon overproduction in order to prevent aggre-
gate formation [27]. Another periplasmic protease, Tsp, is known to
have a preference for unfolded substrates with hydrophobic amino
acids at its C-terminus [28]. Further experiments are necessary to
conﬁrm whether BabA547, expressed in the E. coli periplasmic
space, is a substrate for these, or other, periplasmic proteases.
However, it is possible that the presence a C-terminal hexa-lysine
tag interacts with other amino acids in the protein to enhance cor-
rect folding or is able to prevent protease access to susceptible
cleavage sites. Firm conclusions cannot be drawn until BabA struc-
tural information becomes available.
30 N. Hage et al. / Protein Expression and Puriﬁcation 106 (2015) 25–30Using an ELISA, it was conﬁrmed that BabA547-6K possessed
binding activity towards Lewisb–HSA glycoconjugates. Further-
more, comparable to the reported activity of the native BabA
protein [13], no non-speciﬁc binding to the related Lewisy–HSA
glycoconjugates was found. These ﬁndings suggest that our
recombinant protein is correctly folded during expression and
may provide useful insight into the BabA adhesin through struc-
tural and biophysical studies, which are currently being pursued
by our laboratory. Further study is also underway to determine if
this recombinant expression strategy is applicable to different
BabA truncates and other bacterial adhesins.Conclusion
This work shows that the presence of a C-terminal hexa-lysine
tag sequence greatly improves the total yield of a recombinant
BabA protein expressed in the periplasmic space of E. coli. Once
puriﬁed, the recombinant protein retains its binding afﬁnity
towards Lewisb antigens and can therefore be used for further bio-
physical and structural characterisation to gain insight into the
BabA adhesin.
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